Table 1.
Baseline Demographics and Drug-Use Characteristics by HCV Status (N = 114)
| Category | HCV+ | HCV− | p |
|---|---|---|---|
| HCV status (n, %) | 69 (61%) | 45 (39%) | |
| Age, years (M ± SD) | 41.5 ± 8.3 | 39.8 ± 7.7 | .28 |
| Male (n, %) | 45 (65%) | 27 (60%) | .57 |
| Non-Caucasian (n, %) | 40 (58%) | 32 (71%) | .16 |
| Education (M ± SD) | 11.6 ± 1.5 | 12.1 ± 1.4 | .10 |
| Net income, 30 days (M ± SD) | $694 ± 1280 | $560 ± 813 | .53 |
| Heroin use, years (M ± SD) | 13.7 ± 8.8 | 13.7 ± 8.2 | .63 |
| Cocaine use, years (M ± SD) | 12.6 ± 9.0 | 10.0 ± 7.8 | .15 |
| Other opiate use, 30 days (M ± SD) | 0.1 ± 0.4 | 0.8 ± 2.1 | .03 |
| Money spent on drugs, 30 days (M ± SD) | $2,074.30 ± 1,332.00 | $1,612.40 ± 1,001.90 | .04 |
| Overdose (M ± SD) | 0.8 ± 2.1 | 0.1 ± 0.5 | .013 |
| Route of administration of heroin (n, %) | <.001 | ||
| Intranasal | 9 (13%) | 36 (80%) | |
| Intravenous | 60 (87%) | 9 (20%) | |
| Route of administration of cocaine (n, %) | <.001 | ||
| Intranasal | 1 (1%) | 8 (19%) | |
| Intravenous | 43 (62%) | 5 (11%) | |
| Smoking | 24 (35%) | 31 (55%) | |
| Drinking to intoxication, 30 days (M ± SD) | 0.1 ± 0.8 | 0.5 ± 1.5 | .12 |
| Current tobacco smoking (n, %) | 64 (93%) | 34 (76%) | <.02 |
Note. HIV prevalence was very low in HCV+ and HCV− groups.